MycoMedica

Shelton, US · 2 known investors

MycoMedica Life Sciences is a biopharmaceutical company developing psilocybin-based treatments for mental health and neurodegenerative disorders, including depression, OCD, PMDD, and opioid use disorder. The company conducts clinical trials to establish the safety and efficacy of low-dose psilocybin therapies.